“Bimekizumab Rates of Oral Candidiasis in Patients With Moderate to Severe Plaque Psoriasis: Results from up to 4 Years of Five Phase 3 3b Studies”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s646. Accessed April 18, 2026. https://skin.dermsquared.com/skin/article/view/3869.